The Safetyof Dabigatran Versus Warfarin in Patients Undergoing Atrial Fibrillation Ablation

The safety and optimal strategy of the use of dabigatran versus uninterrupted warfarin in atrial fibrillation ablation is currently unclear. We performed a retrospective analysis between July 2011-October 2012 of all patients undergoing an AF ablation who received uninterrupted warfarin therapy (199...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Atr Fibrillation
Hlavní autoři: Garcia, Luis I, Mascarenhas, Mark A, Ahuja, Kartikya, Aizer, Anthony, Bernstein, Neil, Bernstein, Scott A, Fowler, Steve J, Holmes, Douglas S, Park, David S, Chinitz, Larry
Médium: Artigo
Jazyk:Inglês
Vydáno: Cardiofront, Inc 2014
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4956124/
https://ncbi.nlm.nih.gov/pubmed/27957036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.965
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky